Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Vitamin D vs Acyclovir for Plantar Warts
NCT07196670Phase 4Not yet recruiting
- Sponsor
- Cairo University
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 4, randomised, single-blind trial in plantar wart comparing Intralesional Vitamin D3 with Intralesional Acyclovir (2 arms). Primary endpoint: Percentage of decrease in size and number of plantar warts at 3 months. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
vitamin daciclovir
03
Conditions
plantar wart
Beyond the preview
Go deeper on NCT07196670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07196670.